ANIK – anika therapeutics inc. (US:NASDAQ)
Stock Stats
News
Anika Therapeutics, Inc. (NASDAQ: ANIK) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $37.00 to $25.00. They now have an "outperform" rating on the stock.
Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics
Anika Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Form 10-Q Anika Therapeutics, Inc. For: Sep 30
Form 8-K Anika Therapeutics, Inc. For: Oct 31
Form 8-K Anika Therapeutics, Inc. For: Oct 31
Form SC 13G/A Anika Therapeutics, Inc. Filed by: BlackRock, Inc.
Form 4 Anika Therapeutics, Inc. For: Oct 01 Filed by: Nunes Anne
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.